Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
Clinical trial NCT01047202 · COMPLETED
Trial details
- NCT number
- NCT01047202
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-03-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.